Amigo AI Secures $11M for Clinical AI Evolution
March 11, 2026, 3:42 pm
Location: United States, Washington, Seattle
Employees: 51-200
Founded date: 1995
Location: United States, California, Palo Alto
Employees: 1001-5000
Founded date: 1885
Location: United States, California, Goleta
Employees: 51-200
Founded date: 2009
Total raised: $55.5M
Amigo AI, a New York-based innovator, recently secured $11 million in Series A funding. This investment, led by Madrona, propels its advanced patient-facing clinical AI platform. The company now boasts $17 million in total funding. Amigo AI tackles critical healthcare challenges: workforce shortages and demand for efficient patient care. Its unique "digital residency" training system prepares AI agents rigorously. This ensures high safety standards before patient interaction. Amigo AI aims to redefine patient engagement, streamline clinical workflows, and expand care access globally.
Amigo AI, a New York-based healthcare technology firm, has announced a significant Series A funding round. The company secured $11 million. Madrona led the investment, with Optum Ventures also participating. This latest capital infusion brings Amigo AI's total funding to $17 million. Earlier investments included a seed round co-led by General Catalyst and GSV Ventures. The new funds will fuel expanded operations and accelerated development efforts. This move underscores growing confidence in patient-facing artificial intelligence solutions.
The healthcare industry faces immense pressure. A global health worker shortage looms large. Projections suggest an 11 million deficit by 2030. This critical gap drives demand for innovative technological solutions. Amigo AI directly addresses this crisis. Its platform deploys autonomous clinical AI agents. These agents handle high-value patient tasks. They aim to boost efficiency and expand care capacity.
Amigo AI differentiates itself through a unique training methodology. It employs a proprietary "digital residency" system. This approach mirrors human physician training. AI agents undergo millions of simulated clinical scenarios. These simulations are tailored to specific healthcare organizations and their patient populations. Training emphasizes adversarial and edge-case situations. Agents are constantly evaluated. Metrics include accuracy, empathy, and harm prevention. The goal is a 100% safety pass rate before real-world patient interaction. This rigorous preparation builds robust, reliable clinical AI agents.
The results of this intensive training are compelling. Amigo AI's agents have completed over 3 million patient encounters globally. This occurred in just six months. No safety incidents have been reported. This track record demonstrates the platform's reliability and patient safety focus. Healthcare providers seek dependable AI solutions. Amigo AI delivers proven performance.
Amigo AI agents engage directly with patients. They manage various healthcare workflows. These include intake, triage, and personalized care navigation. They also provide 24/7 patient support. By automating these processes, the platform frees up human care teams. Clinicians can then focus on more complex cases. This strategic reallocation of resources improves overall patient outcomes.
The platform's architecture is also innovative. It supports collaboration among multiple AI agents. They share unified patient context in real time. This capability streamlines complex, team-based workflows. It eliminates the need for fragmented point solutions. Healthcare organizations gain a cohesive, integrated AI system. This fosters greater operational synergy.
Amigo AI is already impacting healthcare organizations worldwide. Current partners include Eucalyptus, Diverge Health, and The Care Clinic. These partnerships showcase the platform's adaptability and global reach. Its enterprise deployment is robust. It integrates natively with major electronic health record (EHR) systems. These include Epic, Oracle Health, and Athenahealth. This broad compatibility ensures seamless adoption.
Leadership appointments further strengthen Amigo AI's position. Dr. Jay Shah now serves as Chief Medical Advisor. Dr. Shah is Chief of the Medical Staff at Stanford Health Care. His extensive clinical experience lends significant credibility. This strategic appointment reinforces Amigo AI's commitment to clinical excellence and safety standards.
Compliance and accessibility are paramount for healthcare technology. Amigo AI's platform supports over 100 languages. It adheres to strict regulatory standards. These include HIPAA, SOC 2 Type II, and GDPR compliance. This comprehensive compliance framework ensures data security and patient privacy across diverse global markets.
The investment reflects a growing market need for advanced healthcare AI. Amigo AI is positioned to lead this transformation. Its focus on patient safety and rigorous training sets a high industry benchmark. The company's technology offers a scalable solution. It addresses critical shortages and enhances care delivery.
This funding will expand Amigo AI's footprint. It will also accelerate product development. The aim is to deliver even more sophisticated clinical AI capabilities. The company is committed to defining the standard for safe, patient-facing AI. Its trajectory suggests a significant role in the future of healthcare. Amigo AI is building intelligent systems. These systems promise better health outcomes and broader care access for all.
Amigo AI, a New York-based healthcare technology firm, has announced a significant Series A funding round. The company secured $11 million. Madrona led the investment, with Optum Ventures also participating. This latest capital infusion brings Amigo AI's total funding to $17 million. Earlier investments included a seed round co-led by General Catalyst and GSV Ventures. The new funds will fuel expanded operations and accelerated development efforts. This move underscores growing confidence in patient-facing artificial intelligence solutions.
The healthcare industry faces immense pressure. A global health worker shortage looms large. Projections suggest an 11 million deficit by 2030. This critical gap drives demand for innovative technological solutions. Amigo AI directly addresses this crisis. Its platform deploys autonomous clinical AI agents. These agents handle high-value patient tasks. They aim to boost efficiency and expand care capacity.
Amigo AI differentiates itself through a unique training methodology. It employs a proprietary "digital residency" system. This approach mirrors human physician training. AI agents undergo millions of simulated clinical scenarios. These simulations are tailored to specific healthcare organizations and their patient populations. Training emphasizes adversarial and edge-case situations. Agents are constantly evaluated. Metrics include accuracy, empathy, and harm prevention. The goal is a 100% safety pass rate before real-world patient interaction. This rigorous preparation builds robust, reliable clinical AI agents.
The results of this intensive training are compelling. Amigo AI's agents have completed over 3 million patient encounters globally. This occurred in just six months. No safety incidents have been reported. This track record demonstrates the platform's reliability and patient safety focus. Healthcare providers seek dependable AI solutions. Amigo AI delivers proven performance.
Amigo AI agents engage directly with patients. They manage various healthcare workflows. These include intake, triage, and personalized care navigation. They also provide 24/7 patient support. By automating these processes, the platform frees up human care teams. Clinicians can then focus on more complex cases. This strategic reallocation of resources improves overall patient outcomes.
The platform's architecture is also innovative. It supports collaboration among multiple AI agents. They share unified patient context in real time. This capability streamlines complex, team-based workflows. It eliminates the need for fragmented point solutions. Healthcare organizations gain a cohesive, integrated AI system. This fosters greater operational synergy.
Amigo AI is already impacting healthcare organizations worldwide. Current partners include Eucalyptus, Diverge Health, and The Care Clinic. These partnerships showcase the platform's adaptability and global reach. Its enterprise deployment is robust. It integrates natively with major electronic health record (EHR) systems. These include Epic, Oracle Health, and Athenahealth. This broad compatibility ensures seamless adoption.
Leadership appointments further strengthen Amigo AI's position. Dr. Jay Shah now serves as Chief Medical Advisor. Dr. Shah is Chief of the Medical Staff at Stanford Health Care. His extensive clinical experience lends significant credibility. This strategic appointment reinforces Amigo AI's commitment to clinical excellence and safety standards.
Compliance and accessibility are paramount for healthcare technology. Amigo AI's platform supports over 100 languages. It adheres to strict regulatory standards. These include HIPAA, SOC 2 Type II, and GDPR compliance. This comprehensive compliance framework ensures data security and patient privacy across diverse global markets.
The investment reflects a growing market need for advanced healthcare AI. Amigo AI is positioned to lead this transformation. Its focus on patient safety and rigorous training sets a high industry benchmark. The company's technology offers a scalable solution. It addresses critical shortages and enhances care delivery.
This funding will expand Amigo AI's footprint. It will also accelerate product development. The aim is to deliver even more sophisticated clinical AI capabilities. The company is committed to defining the standard for safe, patient-facing AI. Its trajectory suggests a significant role in the future of healthcare. Amigo AI is building intelligent systems. These systems promise better health outcomes and broader care access for all.